UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

PIK3CA mutations, PTEN, and pHER2 expression and impact on outcome in HER2-positive early-stage breast cancer patients treated with adjuvant chemotherapy and trastuzumab

Annals of oncology, 2012-08, Vol.23 (8), p.2034-2042

2012

Volltextzugriff (PDF)

Breast cancer after bilateral risk-reducing mastectomy

Clinical genetics, 2011-05, Vol.79 (5), p.431-437

2011

Volltextzugriff (PDF)

Rates of re‐excision and conversion to mastectomy after breast‐conserving surgery with or without oncoplastic surgery: a nationwide population‐based study

British journal of surgery, 2020-12, Vol.107 (13), p.1762-1772

2020

Volltextzugriff (PDF)

A kinase inhibitor screen identifies Mcl-1 and Aurora kinase A as novel treatment targets in antiestrogen-resistant breast cancer cells

Oncogene, 2015-08, Vol.34 (32), p.4199-4210

2015

Volltextzugriff (PDF)

Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy

Oncogene, 2015-04, Vol.34 (15), p.1919-1927

2015

Volltextzugriff (PDF)

Evaluation of tumor-infiltrating lymphocytes and association with prognosis in BRCA-mutated breast cancer

Acta oncologica, 2019-03, Vol.58 (3), p.363-370

2019

Volltextzugriff (PDF)

Prognostic significance of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in primary breast cancer

British journal of cancer, 1998-03, Vol.77 (6), p.932-940

1998

Volltextzugriff (PDF)

Clinical and molecular characterization of BRCA-associated breast cancer: results from the DBCG

Acta oncologica, 2018-01, Vol.57 (1), p.95-101

2018

Volltextzugriff (PDF)

Correction: Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy

Oncogene, 2020-03, Vol.39 (10), p.2229-2230

2020

Volltextzugriff (PDF)

Correction: Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy

Oncogene, 2018-10, Vol.37 (41), p.5585-5586

2018

Volltextzugriff (PDF)

Independent prognostic value of angiogenesis and the level of plasminogen activator inhibitor type I in breast cancer patients

British journal of cancer, 2003-01, Vol.88 (1), p.102-108

2003

Volltextzugriff (PDF)

Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group

JNCI : Journal of the National Cancer Institute, 2021-07, Vol.113 (7), p.808-819

2021

Volltextzugriff (PDF)

164P Current use of breast cancer multigene signatures in clinical practice among European experts: Results from the PROCURE Project

Annals of oncology, 2022-09, Vol.33, p.S613

2022

Volltextzugriff (PDF)

35P European consensus on the utility of breast cancer multigene signatures in routine clinical practice: PROCURE project final results

Annals of oncology, 2022-05, Vol.33, p.S138-S139

2022

Volltextzugriff (PDF)

184P From breast and gastric to beyond: Expanding HER2 detection in solid tumors using quantitative RNA and protein analysis

Annals of oncology, 2024-09, Vol.35, p.S289-S289

2024

Volltextzugriff (PDF)

Abstract P3-11-03: Validation of CIN4 in the DBCG 89D clinical cohort

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P3-P3-11-03

2019

Volltextzugriff (PDF)

Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy

Oncogene, 2015-04, p.1919

2015

Volltextzugriff (PDF)

Abstract P1-07-10: Prediction of 10yr distant recurrence (DR) using the Prosigna® (PAM50) assay in histological subgroups of a Danish breast cancer group (DBCG) cohort of postmenopausal Danish women with hormone receptor-positive (HR+) early breast cancer (EBC) allocated to 5yr of endocrine therapy (ET) alone

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P1-P1-07-10

2017

Volltextzugriff (PDF)

Mortality Rates Among Early-Stage Hormone Receptor-Positive Breast Cancer Patients: A Population-Based Cohort Study in Denmark

JNCI : Journal of the National Cancer Institute, 2011-09, Vol.103 (18), p.1363-1372

2011

Volltextzugriff (PDF)

A Multi-Stain Breast Cancer Histological Whole-Slide-Image Data Set from Routine Diagnostics

Scientific data, 2023-08, Vol.10 (1), p.562-6, Article 562

2023

Volltextzugriff (PDF)

Abstract P2-08-10: Validation of prediction of local recurrence (LR) by Prosigna® (PAM50) in a Danish breast cancer cooperative group (DBCG) cohort of hormone receptor positive (HR+), postmenopausal early breast cancer (EBC) patients allocated to 5yr of endocrine therapy (ET)

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.P2-P2-08-10

2016

Volltextzugriff (PDF)

Quantitative proteomics of primary tumors with varying metastatic capabilities using stable isotope-labeled proteins of multiple histogenic origins

Proteomics (Weinheim), 2012-07, Vol.12 (13), p.2139-2148

2012

Volltextzugriff (PDF)

P35 Phage display-derived human scFv antibodies isolated by binding to live primary breast cancer cells recognize GRP78

European journal of cancer supplements, 2007, Vol.5 (8), p.26-26

2007

Volltextzugriff (PDF)

P26 Tumor infiltrating lymphocytes in medullary breast cancer

European journal of cancer supplements, 2007, Vol.5 (8), p.26-26

2007

Volltextzugriff (PDF)

P4 Genes for normalization of qRT-PCR data in breast cancer

European journal of cancer supplements, 2007, Vol.5 (8), p.28-28

2007

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(44)

Publikationsform

Artikel
(46)
Tagungsberichte
(1)

Sprache

Englisch
(47)

Erscheinungsjahr

n.n

Thema

Science & Technology
(17)
Life Sciences & Biomedicine
(16)
Oncology
(14)
Breast Cancer
(13)
Humans
(13)
Female
(10)
Tumors
(8)
Biological And Medical Sciences
(7)
Adult
(6)
Aged
(6)
Breast Neoplasms - Genetics
(6)
Medicin Och Hälsovetenskap
(6)
Middle Aged
(6)
Survival Analysis
(6)
Biomarkers
(5)
Breast Neoplasms - Drug Therapy
(5)
Cell Biology
(5)
Endocrine Therapy
(5)
Gynecology. Andrology. Obstetrics
(5)
Hematology, Oncology And Palliative Medicine
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

PIK3CA mutations, PTEN, and pHER2 expression and impact on outcome in HER2-positive early-stage breast cancer patients treated with adjuvant chemotherapy and trastuzumab

Breast cancer after bilateral risk-reducing mastectomy

Rates of re‐excision and conversion to mastectomy after breast‐conserving surgery with or without oncoplastic surgery: a nationwide population‐based study

A kinase inhibitor screen identifies Mcl-1 and Aurora kinase A as novel treatment targets in antiestrogen-resistant breast cancer cells

Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy

Evaluation of tumor-infiltrating lymphocytes and association with prognosis in BRCA-mutated breast cancer

Prognostic significance of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in primary breast cancer

Clinical and molecular characterization of BRCA-associated breast cancer: results from the DBCG

Correction: Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy

Correction: Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy

Independent prognostic value of angiogenesis and the level of plasminogen activator inhibitor type I in breast cancer patients

Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group

164P Current use of breast cancer multigene signatures in clinical practice among European experts: Results from the PROCURE Project

35P European consensus on the utility of breast cancer multigene signatures in routine clinical practice: PROCURE project final results

184P From breast and gastric to beyond: Expanding HER2 detection in solid tumors using quantitative RNA and protein analysis

Abstract P3-11-03: Validation of CIN4 in the DBCG 89D clinical cohort

Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy

Mortality Rates Among Early-Stage Hormone Receptor-Positive Breast Cancer Patients: A Population-Based Cohort Study in Denmark

A Multi-Stain Breast Cancer Histological Whole-Slide-Image Data Set from Routine Diagnostics

Abstract P2-08-10: Validation of prediction of local recurrence (LR) by Prosigna® (PAM50) in a Danish breast cancer cooperative group (DBCG) cohort of hormone receptor positive (HR+), postmenopausal early breast cancer (EBC) patients allocated to 5yr of endocrine therapy (ET)

Quantitative proteomics of primary tumors with varying metastatic capabilities using stable isotope-labeled proteins of multiple histogenic origins

P35 Phage display-derived human scFv antibodies isolated by binding to live primary breast cancer cells recognize GRP78

P26 Tumor infiltrating lymphocytes in medullary breast cancer

P4 Genes for normalization of qRT-PCR data in breast cancer

Suchergebnisse filtern